Neuroprotective Effect of the Ginsenoside Rg1 on Cerebral Ischemic Injury in Vivo and in Vitro Is Mediated by PPAR γ -Regulated Antioxidative and Anti-Inflammatory Pathways

Evidence-based Complementary and Alternative Medicine

Volumn 2017, Issue , 2017, Pages

  Li, Yang ^a,b   Guan, Yue ^a   Wang, Ying ^c   Yu, Chun Lei ^a   Zhai, Feng Guo ^a   Guan, Li Xin ^a  

^a MUDANJIANG MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^c Affiliated Hospital of Mudanjiang Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GINSENOSIDE RG 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 85021628993     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2017/7842082     Document Type: Article

References (37)

1. J. Pan, A.-A. Konstas, B. Bateman, G. A. Ortolano, and J. Pile-Spellman, "Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies, " Neuroradiology, vol. 49, no. 2, pp. 93-102, 2007.
2. W. E. Sonntag et al., "Frontiers in neuroscienceregulation of cerebrovascular aging, " in Brain Aging: Models, Methods, and Mechanisms, D. R. Riddle, Ed., CRCPress/Taylor&FrancisTaylor & Francis Group, LLC., Boca Raton, FL, USA, 2007.
3. G. F. Hamann, Y. Okada, and G. J. del Zoppo, "Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion, " Journal of Cerebral Blood Flow & Metabolism, vol. 6, pp. 1373-1378, 1996.
4. G. W. Albers, L. B. Goldstein, D. C. Hess et al., "StrokeTreatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies, " Stroke, vol. 42, no. 9, pp. 2645-2650, 2011.
5. P. Deb, S. Sharma, and K. M. Hassan, "Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis, " Pathophysiology, vol. 17, no. 3, pp. 197-218, 2010.
6. Y. Liu, J. M. Kong, L. S. Chia, and N. K. Goh, "Synergistic effect of traditional Chinesemedicine, " Asian Journal ofChemistry, vol. 19, no. 2, pp. 867-882, 2007.
7. L. Shen and J. Zhang, "NMDA receptor and iNOS are involved in the effects of ginsenoside Rg1 on hippocampal neurogenesis in ischemic gerbils, " Neurological Research, vol. 29, no. 3, pp. 270-273, 2007.
8. G.-Q. Zheng, W. Cheng, Y. Wang et al., "Ginseng total saponins enhance neurogenesis after focal cerebral ischemia, " Journal of Ethnopharmacology, vol. 133, no. 2, pp. 724-728, 2011.
9. Y. Zhou, H. Q. Li, and L. Lu, "Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression, " Phytomedicine, vol. 21, no. 7, pp. 998-1003, 2014.
10. J.-L. Liu, J.-W. Jin, S.-J. Pei, and C. Wang, "Flurbiprofen axetil promotes neuroprotection by activation of cerebral peroxisome proliferator-activated receptor gammaafter focal cerebral ischemia in rats, " Chinese Medical Journal, vol. 125, no. 20, pp. 3719-3724, 2012.
11. Z.-J. Liu, W. Liu, L. Liu, C. Xiao, Y. Wang, and J.-S. Jiao, "Curcumin protects neuron against cerebral ischemia-induced inflammation through improving PPAR-gamma function, " Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 470975, 10 pages, 2013, article 470975.
12. H.-X. Ni, N.-J. Yu, and X.-H. Yang, "The study of ginsenoside on PPAR expression of mononuclear macrophage in type 2 diabetes, " Molecular Biology Reports, vol. 37, no. 6, pp. 2975-2979, 2010.
13. Y. Yang et al., "Ginsenoside Rg1 suppressed inflammation and neuron apoptosis by activating PPARgamma/HO-1 in hippocampus in rat model of cerebral ischemia-reperfusion injury, " International Journal of Clinical and Experimental Pathology, vol. 8, no. 3, pp. 2484-2494, 2015.
14. E. Z. Longa, P. R. Weinstein, S. Carlson, and R. Cummins, "Reversible middle cerebral artery occlusion without craniectomy in rats, " Stroke, vol. 20, no. 1, pp. 84-91, 1989.
15. D. W. Choi, M. Maulucci-Gedde, and A. R. Kriegstein, "Glutamate neurotoxicity in cortical cell culture, " Journal of Neuroscience, vol. 7, no. 2, pp. 357-368, 1987.
16. J. Xiang, Y. Tang, Z. Zhou et al., Canadian Journal of Physiology and Pharmacology, vol. 88, no. 9, pp. 907-917, 2010.
17. D. Zierath, J. Hadwin, A. Savos, K. T. Carter, A. Kunze, and K. J. Becker, "Anamnestic recall of stroke-related deficits: An animal model, " Stroke, vol. 41, no. 11, pp. 2653-2660, 2010.
18. A. Mdzinarishvili, C. Kiewert, V. Kumar, M. Hillert, and J. Klein, "Bilobalide prevents ischemia-induced edema formation in vitro and in vivo, " Neuroscience, vol. 144, no. 1, pp. 217-222, 2007.
19. U. Bruer, M. K. Weih, N. K. Isaev et al., "Induction of tolerance in rat cortical neurons: hypoxic preconditioning, " FEBS Letters, vol. 414, no. 1, pp. 117-121, 1997.
20. M. Lin, W. Sun, W. Gong, Y. Ding, Y. Zhuang, andQ. Hou, "Ginsenoside Rg1 protects against transient focal cerebral ischemic injury and suppresses its systemic metabolic changes in cerabral injury rats, " Acta Pharmaceutica Sinica B, vol. 5, no. 3, pp. 277-284, 2015.
21. S. W. Ryter and A. M. K. Choi, "Heme oxygenase-1: redox regulation of a stress protein in lung and cell culture models, " Antioxidants and Redox Signaling, vol. 7, no. 1-2, pp. 80-91, 2005.
22. Y. Jiang, L. Li, B. Liu, Y. Zhang, Q. Chen, and C. Li, "PPAR upregulation induced by vagus nerve stimulation exerts anti-inflammatory effect in cerebral ischemia/reperfusion rats, " Medical Science Monitor, vol. 21, pp. 268-275, 2015.
23. C.-L. Xie, W.-W. Wang, X.-D. Xue, S.-F. Zhang, J. Gan, and Z.-G. Liu, "A systematic review andmeta-analysis ofGinsenoside-Rg1 (G-Rg1) in experimental ischemic stroke, " Scientific Reports, vol. 5, article no. 7790, 2015.
24. T. Wong, H. Chen, R. Gau, J. Yen, J. Suen, and H. M. Ashour, "HemeOxygenase-1-expressing dendritic cells promote Foxp3+ regulatory t cell differentiation and induce less severe airway inflammation in murine models, " PLOS ONE, vol. 11, no. 12, article e0168919, 2016.
25. J. Jung, M. Choi, Y. Y. Lee, B. Moon, J. Park, and H. Kim, "Suppression of lipopolysaccharide-induced neuroinflammation by morin via MAPK, PI3K/Akt, and PKA/HO-1 signaling pathway modulation, " Journal of Agricultural and Food Chemistry, vol. 65, no. 2, pp. 373-382, 2017.
26. X. Fan and L. Mu, "The role of heme oxygenase-1 (HO-1) in the regulation of inflammatory reaction, neuronal cell proliferation and apoptosis in rats after intracerebral hemorrhage (ICH), " Neuropsychiatric Disease and Treatment, vol. Volume 13, pp. 77-85, 2017.
27. Y. Zhao, A. Patzer, T. Herdegen, P. Gohlke, and J. Culman, "Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats, " The FASEB Journal, vol. 20, no. 8, pp. 1162-1175, 2006.
28. S.-D. Chen, H.-Y. Wu, D.-I. Yang et al., "Effects of rosiglitazone on global ischemia-induced hippocampal injury and expression of mitochondrial uncoupling protein 2, " Biochemical and Biophysical Research Communications, vol. 351, no. 1, pp. 198-203, 2006.
29. A. R. Carta, L. Frau, A. Pisanu, J. Wardas, S. Spiga, and E. Carboni, "Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model, " Neuroscience, vol. 194, pp. 250-261, 2011.
30. C. De Nuccio, A. Bernardo, C. Cruciani, R. De Simone, S. Visentin, and L. Minghetti, "Peroxisome proliferator activated receptor-agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: effects on mitochondrial functions and differentiation, " Experimental Neurology, vol. 271, pp. 506-514, 2015.
31. J.-H. Yi, S.-W. Park, N. Brooks, B. T. Lang, and R. Vemuganti, "PPAR agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms, " Brain Research, vol. 1244, pp. 164-172, 2008.
32. T. Bozina, J. Sertic, J. Lovric, B. Jelakovic, I. simic, and Z. Reiner, "Interaction of genetic risk factors confers increased risk for metabolic syndrome: The role of peroxisome proliferator-Activated receptor, "Genetic Testing andMolecular Biomarkers, vol. 18, no. 1, pp. 32-40, 2014.
33. D. A. Ridder and M. Schwaninger, "NF-B signaling in cerebral ischemia, " Neuroscience, vol. 158, no. 3, pp. 995-1006, 2009.
34. B. V. Zlokovic, "The blood-brain barrier in health and chronic neurodegenerative disorders, " Neuron, vol. 57, no. 2, pp. 178-201, 2008.
35. Y.-F. Zhang, X.-J. Fan, X. Li et al., "Ginsenoside Rg1 protects neurons from hypoxic-ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltagedependent Ca2+ channels, " European Journal of Pharmacology, vol. 586, no. 1-3, pp. 90-99, 2008.
36. Q. He et al., "Neuroprotective effects of ginsenoside Rg1 against oxygen-glucose deprivation in cultured hippocampal neurons, " Journal of the ChineseMedical Association, vol. 77, no. 3, pp. 142-149, 2014.
37. Z.-G. Sun, L.-P. Chen, F.-W. Wang, C.-Y. Xu, andM. Geng, "Protective effects of ginsenoside Rg1 against hydrogen peroxide-induced injury in human neuroblastoma cells, " Neural Regeneration Research, vol. 11, no. 7, pp. 1159-1164, 2016.